CytoMed Therapeutics (GDTC) Payables (2021 - 2025)
CytoMed Therapeutics (GDTC) posted Payables of $373994.6 for Q4 2025, down 21.71% sequentially from $477690.0 in Q2 2025, and up 3.93% YoY from $359855.1 in Q4 2024.
CytoMed Therapeutics (GDTC) Payables (2021 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Payables for 5 years, with the latest figure at $373994.6 in Q4 2025.
- Quarterly Payables rose 3.93% year-over-year to $373994.6 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $373994.6 (up 3.93% YoY) and the FY2025 annual result came in at $370999.5, up 3.71% from the prior year.
- Payables slipped to $373994.6 in Q4 2025 per GDTC's latest filing, from $477690.0 in the prior quarter.
- Over five years, Payables peaked at $541269.6 in Q4 2022 and troughed at $266892.0 in Q2 2023.
- A 5-year average of $399377.7 and a median of $393854.2 in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2025: Payables dropped 23.57% in 2023, then jumped 51.07% in 2025.
- Over 5 years, Payables stood at $445393.4 in 2021, then advanced by 21.53% to $541269.6 in 2022, then decreased by 23.57% to $413713.8 in 2023, then slipped by 13.02% to $359855.1 in 2024, then increased by 3.93% to $373994.6 in 2025.
- According to Business Quant data, Payables over the past three periods registered $373994.6, $477690.0, and $359855.1 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 35.57 Mn |
| 10 | CytoMed Therapeutics | 9.97 Mn | 8.35 Mn | - | 373,994.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 373,994.64 |
| Jun 30, 2025 | 477,690.00 |
| Dec 31, 2024 | 359,855.09 |
| Jun 30, 2024 | 316,213.00 |
| Dec 31, 2023 | 413,713.77 |
| Jun 30, 2023 | 266,892.00 |
| Dec 31, 2022 | 541,269.57 |
| Dec 31, 2021 | 445,393.39 |